查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1584646

医院和护理机构益生菌的全球市场：按产品、按应用、按地区、趋势分析、竞争格局、预测，2019-2030

Hospital and Nursing Home Probiotics Market, By Product; By Application; By Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa ), Global Trend Analysis, Competitive Landscape & Forecast, 2019-2030
出版日期: | 出版商: Blueweave Consulting | 英文 510 Pages | 商品交期: 2-3个工作天内

价格
简介目录

到 2030 年，全球医院和疗养院益生菌市场将超过 9,100 万美元

由于人们对肠道健康的认识不断提高、越来越多地使用益生菌来预防感染疾病、人口不断增长以及对个人化医疗的需求不断增长，全球医院和疗养院的益生菌市场正在蓬勃发展。

领先的策略咨询和市场研究公司 BlueWeave Consulting 在最新研究中估计，到 2023 年，全球医院和疗养院益生菌市场以金额为准6,900 万美元。 BlueWeave 预测，在 2024 年至 2030 年的预测期内，医院和疗养院益生菌的全球市场规模将以 4.30% 的复合年增长率增长，到 2030 年将达到 9,110 万美元。人们越来越认识到益生菌在促进肠道健康和免疫力方面的作用，特别是在老年人和慢性疾病患者等弱势群体中，这推动了医院和疗养院益生菌的全球市场。胃肠道疾病的盛行率不断上升，对非侵入性治疗的需求不断增长，以及在医疗机构中越来越多地采用益生菌来预防感染和支持康復，也推动了市场的成长。此外，益生菌配方的进步和医疗保健成本的上升进一步推动了医院和疗养院的需求。

机会－对个人化医疗的日益偏好

个人化医疗的不断成长趋势是全球医院和疗养院益生菌市场的关键成长要素。随着人们对微生物组个体差异的认识不断增强，医疗保健提供者正在转向客製化益生菌治疗来解决特定的健康状况。这种方法可确保更好的患者治疗效果，尤其是消化器官系统、免疫系统和心理健康问题。在微生物组研究和基因组分析进展的支持下，个人化益生菌配方正在刺激医院和疗养院的需求，并推动市场扩张。

地缘政治紧张局势加剧对全球医院和护理机构益生菌市场的影响

不断升级的地缘政治紧张局势正在影响全球医院和疗养院益生菌市场，导致供应链中断、贸易限制和关税增加，特别是可能影响原材料的采购和分销。这可能会导致製造和物流的成本增加、延误和不确定性。此外，关键地区的政治不稳定可能会限制市场进入并影响产品的供应和定价。医疗保健预算也可能变得更加紧张，这可能会减少医院和疗养院对益生菌的需求。

肠道健康领域按应用引领市场

人们对消化器官系统健康的认识不断提高，以及益生菌在维持健康肠道微生物组方面的益处，推动肠道健康领域在全球医院和疗养院益生菌市场中占据最大份额。益生菌广泛应用于医院和疗养院，以预防和治疗常见的胃肠道疾病。肠道健康益生菌的需求源自于其改善消化和改善整体健康结果的功效。

竞争格局

全球医院和疗养院益生菌市场竞争非常激烈，许多公司都在争夺更大的市场占有率。市场主要企业包括 Bio-K Plus International、American Lifeline、Rising Pharmaceuticals、Becton Dickinson and Company、NutraScience Labs、Vitakem Nutraceuticals、Probium、Protexin、Nutraceutix、Nebraska Cultures、Mercola、Eva Nutra、UP4 Probiotics 等。这些公司正在利用各种策略，包括增加研发活动投资、併购、合资、联盟、许可协议以及发布新产品和服务，以进一步占领全球医院和疗养院益生菌市场。

本报告的详细分析提供了有关全球医院和疗养院益生菌市场的成长潜力、未来趋势和统计数据的资讯。它还重点关注推动市场总规模预测的因素。该报告致力于提供全球医院和疗养院益生菌市场的最新技术趋势以及产业见解，帮助决策者做出策略决策。此外，我们也分析了市场的成长动力、挑战和竞争力。

目录

第一章 研究框架

第 2 章执行摘要

第三章 全球医院和护理机构益生菌市场洞察

  • 产业价值链分析
  • DROC分析
    • 生长促进因子
      • 提高对益生菌的认识
      • 医疗费用增加
      • 慢性病流行
    • 抑制因素
      • 益生菌市场缺乏标准化
      • 与益生菌相关的监管挑战
      • 益生菌产品高成本
    • 机会
      • 个性化医疗的成长趋势
      • 扩大益生菌的应用范围
      • 医疗保健需求日益增长的发展中国家
    • 任务
      • 确保益生菌菌株的品质和一致性
      • 与非专利药的竞争
  • 科技进步/最新趋势
  • 法律规范
  • 波特五力分析

第四章医院和护理机构的全球益生菌市场：行销策略

第五章医院和护理机构的全球益生菌市场：价格分析

第六章医院和护理机构的全球益生菌市场：区域分析

  • 全球医院和护理机构益生菌市场区域分析，2023 年
  • 2024-2030年全球益生菌市场对医院和护理机构的吸引力分析

第七章全球医院和护理机构益生菌市场概述

  • 2019-2030年市场规模及预测
    • 按金额
  • 市场占有率及预测
    • 副产品
      • 乳酸菌
      • 双歧桿菌
      • 革兰氏阳性球菌
      • 其他的
    • 按用途
      • 肠道健康
      • 免疫
      • 健康
      • 其他的
    • 按地区
      • 北美洲
      • 欧洲
      • 亚太地区 (APAC)
      • 拉丁美洲 (LATAM)
      • 中东和非洲 (MEA)

第八章 北美医院和护理机构益生菌市场

  • 2019-2030年市场规模及预测
    • 按金额
  • 市场占有率及预测
    • 副产品
    • 按用途
    • 按国家/地区
      • 美国
      • 加拿大

第九章欧洲医院和护理机构益生菌市场

  • 2019-2030年市场规模及预测
    • 按金额
  • 市场占有率及预测
    • 副产品
    • 按用途
    • 按国家/地区
      • 德国
      • 英国
      • 义大利
      • 法国
      • 西班牙
      • 比利时
      • 俄罗斯
      • 荷兰
      • 其他欧洲国家

第十章亚太地区医院和护理机构益生菌市场

  • 2019-2030年市场规模及预测
    • 按金额
  • 市场占有率及预测
    • 副产品
    • 按用途
    • 按国家/地区
      • 中国
      • 印度
      • 日本
      • 韩国
      • 澳洲和纽西兰
      • 印尼
      • 马来西亚
      • 新加坡
      • 越南
      • 亚太地区其他地区

第十一章拉丁美洲医院和护理机构的益生菌市场

  • 2019-2030年市场规模及预测
    • 按金额
  • 市场占有率及预测
    • 副产品
    • 按用途
    • 按国家/地区
      • 巴西
      • 墨西哥
      • 阿根廷
      • 秘鲁
      • 其他拉丁美洲

第十二章中东和非洲医院和护理机构的益生菌市场

  • 2019-2030年市场规模及预测
    • 按金额
  • 市场占有率及预测
    • 副产品
    • 按用途
    • 按国家/地区
      • 沙乌地阿拉伯
      • 阿拉伯聯合大公国
      • 卡达
      • 科威特
      • 南非
      • 奈及利亚
      • 阿尔及利亚
      • 其他中东/非洲

第十三章竞争格局

  • 主要参与者及其产品列表
  • 2023 年全球医院和护理机构益生菌市场占有率分析
  • 透过管理参数进行竞争基准基准化分析
  • 重大策略发展（合併、收购、联盟等）

第14章地缘政治紧张局势加剧对全球医院和疗养院益生菌市场的影响

第十五章 公司简介（公司简介、财务矩阵、竞争格局、关键人员、主要竞争对手、联络方式、策略展望、SWOT分析）

  • Bio-K Plus International
  • American Lifeline
  • Rising Pharmaceuticals
  • Becton Dickinson and Company
  • NutraScience Labs
  • Vitakem Nutraceuticals
  • Probium
  • Protexin
  • Nutraceutix
  • Nebraska Cultures
  • Mercola
  • Eva Nutra
  • UP4 Probiotics
  • 其他主要企业

第十六章 主要策略建议

第十七章调查方法

简介目录
Product Code: BWC24802

Global Hospital and Nursing Home Probiotics Market Set to Surpass USD 91 Million by 2030

Global Hospital and Nursing Home Probiotics Market is thriving due to a rising awareness about gut health, increasing use of probiotics to prevent infections, growing elderly population, and an increasing demand for personalized healthcare.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated Global Hospital and Nursing Home Probiotics Market size by value at USD 69.00 million in 2023. During the forecast period between 2024 and 2030, BlueWeave expects Global Hospital and Nursing Home Probiotics Market size to expand at a CAGR of 4.30% reaching a value of USD 91.10 million by 2030. Global Hospital and Nursing Home Probiotics Market is driven by the growing awareness about probiotics' role in enhancing gut health and immunity, particularly in vulnerable populations such as the elderly and patients with chronic illnesses. The increasing prevalence of gastrointestinal disorders, rising demand for non-invasive treatments, and the growing adoption of probiotics for infection prevention and recovery support in healthcare settings also fuel market growth. Additionally, advancements in probiotic formulations and increased healthcare expenditures further boost demand in hospitals and nursing homes.

Opportunity - Growing Preference for Personalized Medicine

Rising trend of personalized medicine is a significant growth driver for Global Hospital and Nursing Home Probiotics Market. With increasing awareness of individual microbiome variations, healthcare providers are turning to tailored probiotic treatments to address specific health conditions. This approach ensures better patient outcomes, particularly for digestive, immune, and mental health issues. Personalized probiotic formulations, backed by advancements in microbiome research and genomic analysis, are fueling demand in hospitals and nursing homes, promoting market expansion.

Impact of Escalating Geopolitical Tensions on Global Hospital and Nursing Home Probiotics Market

Escalating geopolitical tensions could impact Global Hospital and Nursing Home Probiotics Market by causing supply chain disruptions, trade restrictions, and increased tariffs, particularly affecting raw material sourcing and distribution. It may lead to higher costs, delays, and uncertainty in manufacturing and logistics. Additionally, market access could be limited due to political instability in key regions, affecting product availability and pricing. Healthcare budgets may also be strained, potentially reducing demand for probiotics in hospital and nursing home settings.

Gut Health Segment Leads the Market by Application

The gut health segment holds the largest share of Global Hospital and Nursing Home Probiotics Market by application, due to the increasing awareness of digestive health and the benefits of probiotics in maintaining a healthy gut microbiome. Probiotics are widely used to prevent and treat gastrointestinal disorders, which are common in hospital and nursing home settings. The demand for gut health probiotics is driven by their effectiveness in improving digestion and overall health outcomes.

Competitive Landscape

Global Hospital and Nursing Home Probiotics Market is fiercely competitive, with numerous companies vying for a larger market share. Major companies in the market include Bio-K Plus International, American Lifeline, Rising Pharmaceuticals, Becton Dickinson and Company, NutraScience Labs, Vitakem Nutraceuticals, Probium, Protexin, Nutraceutix, Nebraska Cultures, Mercola, Eva Nutra, and UP4 Probiotics. These companies use various strategies, including increasing investments in their R&D activities, mergers and acquisitions, joint ventures, collaborations, licensing agreements, and new product and service releases to further strengthen their position in Global Hospital and Nursing Home Probiotics Market.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of Global Hospital and Nursing Home Probiotics Market. It also highlights the factors driving forecasts of total Market size. The report promises to provide recent technological trends in Global Hospital and Nursing Home Probiotics Market and industry insights to help decision-makers make sound strategic decisions. Further, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

1. Research Framework

  • 1.1. Research Objective
  • 1.2. Product Overview
  • 1.3. Market Segmentation

2. Executive Summary

3. Global Hospital and Nursing Home Probiotics Market Insights

  • 3.1. Industry Value Chain Analysis
  • 3.2. DROC Analysis
    • 3.2.1. Growth Drivers
      • 3.2.1.1. Growing awareness of probiotics
      • 3.2.1.2. Increasing healthcare expenditure
      • 3.2.1.3. Rising prevalence of chronic diseases
    • 3.2.2. Restraints
      • 3.2.2.1. Lack of standardization in the probiotic market
      • 3.2.2.2. Regulatory challenges associated with probiotics
      • 3.2.2.3. High costs of probiotic products
    • 3.2.3. Opportunities
      • 3.2.3.1. Growing trend of personalized medicine
      • 3.2.3.2. Expanding applications of probiotics
      • 3.2.3.3. Developing countries with growing healthcare needs
    • 3.2.4. Challenges
      • 3.2.4.1. Ensuring the quality and consistency of probiotic strains
      • 3.2.4.2. Competition from generic products
  • 3.3. Technological Advancements/Recent Developments
  • 3.4. Regulatory Framework
  • 3.5. Porter's Five Forces Analysis
    • 3.5.1. Bargaining Power of Suppliers
    • 3.5.2. Bargaining Power of Buyers
    • 3.5.3. Threat of New Entrants
    • 3.5.4. Threat of Substitutes
    • 3.5.5. Intensity of Rivalry

4. Global Hospital and Nursing Home Probiotics Market: Marketing Strategies

5. Global Hospital and Nursing Home Probiotics Market: Pricing Analysis

6. Global Hospital and Nursing Home Probiotics Market: Geography Analysis

  • 6.1. Global Hospital and Nursing Home Probiotics Market, Geographical Analysis, 2023
  • 6.2. Global Hospital and Nursing Home Probiotics, Market Attractiveness Analysis, 2024-2030

7. Global Hospital and Nursing Home Probiotics Market Overview

  • 7.1. Market Size & Forecast, 2019-2030
    • 7.1.1. By Value (USD Million)
  • 7.2. Market Share and Forecast
    • 7.2.1. By Product
      • 7.2.1.1. Lactobacillus
      • 7.2.1.2. Bifidobacterium
      • 7.2.1.3. Gram-positive Cocci
      • 7.2.1.4. Others
    • 7.2.2. By Application
      • 7.2.2.1. Gut Health
      • 7.2.2.2. Immunity
      • 7.2.2.3. Wellness
      • 7.2.2.4. Others
    • 7.2.3. By Region
      • 7.2.3.1. North America
      • 7.2.3.2. Europe
      • 7.2.3.3. Asia Pacific (APAC)
      • 7.2.3.4. Latin America (LATAM)
      • 7.2.3.5. Middle East and Africa (MEA)

8. North America Hospital and Nursing Home Probiotics Market

  • 8.1. Market Size & Forecast, 2019-2030
    • 8.1.1. By Value (USD Million)
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Application
    • 8.2.3. By Country
      • 8.2.3.1. United States
      • 8.2.3.1.1. By Product
      • 8.2.3.1.2. By Application
      • 8.2.3.2. Canada
      • 8.2.3.2.1. By Product
      • 8.2.3.2.2. By Application

9. Europe Hospital and Nursing Home Probiotics Market

  • 9.1. Market Size & Forecast, 2019-2030
    • 9.1.1. By Value (USD Million)
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Application
    • 9.2.3. By Country
      • 9.2.3.1. Germany
      • 9.2.3.1.1. By Product
      • 9.2.3.1.2. By Application
      • 9.2.3.2. United Kingdom
      • 9.2.3.2.1. By Product
      • 9.2.3.2.2. By Application
      • 9.2.3.3. Italy
      • 9.2.3.3.1. By Product
      • 9.2.3.3.2. By Application
      • 9.2.3.4. France
      • 9.2.3.4.1. By Product
      • 9.2.3.4.2. By Application
      • 9.2.3.5. Spain
      • 9.2.3.5.1. By Product
      • 9.2.3.5.2. By Application
      • 9.2.3.6. Belgium
      • 9.2.3.6.1. By Product
      • 9.2.3.6.2. By Application
      • 9.2.3.7. Russia
      • 9.2.3.7.1. By Product
      • 9.2.3.7.2. By Application
      • 9.2.3.8. The Netherlands
      • 9.2.3.8.1. By Product
      • 9.2.3.8.2. By Application
      • 9.2.3.9. Rest of Europe
      • 9.2.3.9.1. By Product
      • 9.2.3.9.2. By Application

10. Asia Pacific Hospital and Nursing Home Probiotics Market

  • 10.1. Market Size & Forecast, 2019-2030
    • 10.1.1. By Value (USD Million)
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Application
    • 10.2.3. By Country
      • 10.2.3.1. China
      • 10.2.3.1.1. By Product
      • 10.2.3.1.2. By Application
      • 10.2.3.2. India
      • 10.2.3.2.1. By Product
      • 10.2.3.2.2. By Application
      • 10.2.3.3. Japan
      • 10.2.3.3.1. By Product
      • 10.2.3.3.2. By Application
      • 10.2.3.4. South Korea
      • 10.2.3.4.1. By Product
      • 10.2.3.4.2. By Application
      • 10.2.3.5. Australia & New Zealand
      • 10.2.3.5.1. By Product
      • 10.2.3.5.2. By Application
      • 10.2.3.6. Indonesia
      • 10.2.3.6.1. By Product
      • 10.2.3.6.2. By Application
      • 10.2.3.7. Malaysia
      • 10.2.3.7.1. By Product
      • 10.2.3.7.2. By Application
      • 10.2.3.8. Singapore
      • 10.2.3.8.1. By Product
      • 10.2.3.8.2. By Application
      • 10.2.3.9. Vietnam
      • 10.2.3.9.1. By Product
      • 10.2.3.9.2. By Application
      • 10.2.3.10. Rest of APAC
      • 10.2.3.10.1. By Product
      • 10.2.3.10.2. By Application

11. Latin America Hospital and Nursing Home Probiotics Market

  • 11.1. Market Size & Forecast, 2019-2030
    • 11.1.1. By Value (USD Million)
  • 11.2. Market Share & Forecast
    • 11.2.1. By Product
    • 11.2.2. By Application
    • 11.2.3. By Country
      • 11.2.3.1. Brazil
      • 11.2.3.1.1. By Product
      • 11.2.3.1.2. By Application
      • 11.2.3.2. Mexico
      • 11.2.3.2.1. By Product
      • 11.2.3.2.2. By Application
      • 11.2.3.3. Argentina
      • 11.2.3.3.1. By Product
      • 11.2.3.3.2. By Application
      • 11.2.3.4. Peru
      • 11.2.3.4.1. By Product
      • 11.2.3.4.2. By Application
      • 11.2.3.5. Rest of LATAM
      • 11.2.3.5.1. By Product
      • 11.2.3.5.2. By Application

12. Middle East & Africa Hospital and Nursing Home Probiotics Market

  • 12.1. Market Size & Forecast, 2019-2030
    • 12.1.1. By Value (USD Million)
  • 12.2. Market Share & Forecast
    • 12.2.1. By Product
    • 12.2.2. By Application
    • 12.2.3. By Country
      • 12.2.3.1. Saudi Arabia
      • 12.2.3.1.1. By Product
      • 12.2.3.1.2. By Application
      • 12.2.3.2. UAE
      • 12.2.3.2.1. By Product
      • 12.2.3.2.2. By Application
      • 12.2.3.3. Qatar
      • 12.2.3.3.1. By Product
      • 12.2.3.3.2. By Application
      • 12.2.3.4. Kuwait
      • 12.2.3.4.1. By Product
      • 12.2.3.4.2. By Application
      • 12.2.3.5. South Africa
      • 12.2.3.5.1. By Product
      • 12.2.3.5.2. By Application
      • 12.2.3.6. Nigeria
      • 12.2.3.6.1. By Product
      • 12.2.3.6.2. By Application
      • 12.2.3.7. Algeria
      • 12.2.3.7.1. By Product
      • 12.2.3.7.2. By Application
      • 12.2.3.8. Rest of MEA
      • 12.2.3.8.1. By Product
      • 12.2.3.8.2. By Application

13. Competitive Landscape

  • 13.1. List of Key Players and Their Offerings
  • 13.2. Global Hospital and Nursing Home Probiotics Market Share Analysis, 2023
  • 13.3. Competitive Benchmarking, By Operating Parameters
  • 13.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)

14. Impact of Escalating Geopolitical Tensions on Global Hospital and Nursing Home Probiotics Market

15. Company Profiles (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, and SWOT Analysis)

  • 15.1. Bio - K Plus International
  • 15.2. American Lifeline
  • 15.3. Rising Pharmaceuticals
  • 15.4. Becton Dickinson and Company
  • 15.5. NutraScience Labs
  • 15.6. Vitakem Nutraceuticals
  • 15.7. Probium
  • 15.8. Protexin
  • 15.9. Nutraceutix
  • 15.10. Nebraska Cultures
  • 15.11. Mercola
  • 15.12. Eva Nutra
  • 15.13. UP4 Probiotics
  • 15.14. Other Prominent Players

16. Key Strategic Recommendations

17. Research Methodology

  • 17.1. Qualitative Research
    • 17.1.1. Primary & Secondary Research
  • 17.2. Quantitative Research
  • 17.3. Market Breakdown & Data Triangulation
    • 17.3.1. Secondary Research
    • 17.3.2. Primary Research
  • 17.4. Breakdown of Primary Research Respondents, By Region
  • 17.5. Assumptions & Limitations

*Financial information of non-listed companies can be provided as per availability.

**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable